Eli Lilly pausing investment in UK as report warns against ‘limited’ NHS uptake of new drugs – The Pharmaceutical Journal
- Eli Lilly pausing investment in UK as report warns against ‘limited’ NHS uptake of new drugs The Pharmaceutical Journal
- Merck scraps £1bn expansion in the UK over lack of state investment BBC
- MSD to Leave the London’s Francis Crick Institute’ Skylab as part of UK R&D Wind Down PharmiWeb.com
- Pharma says UK is ‘tumbling down’ rankings for investment pharmaphorum
- Merck Abandons $1.3B R&D Center in London, Boots 125 Employees BioSpace